scholarly journals AB0777 A RARE CASE OF A SOLITARY PLASMOCYTOMA OF A LUMBAR VERTEBRA

2021 ◽  
Vol 80 (Suppl 1) ◽  
pp. 1415.2-1415
Author(s):  
D. Khalifa ◽  
H. Hachfi ◽  
N. Ben Chekaya ◽  
M. Brahem ◽  
M. Younes

Background:Solitary plasmocytoma is a rare tumour that represents around 2 to 5% of all plasma cell dyscrasias. It normally affects soft tissu but rarely the bone. Diagnosis is based on histology, the absence of bone marrow involvement.Objectives:To drag attention to think of solitary plasmocytoma of bone when dealing with a vertebral fracture in the absence of the CRAB criteria of multiple myeloma.Methods:We report a rare case of a vertebral fracture of the 4th lumbar vertebra (L4) revealing a solitary plasmocytoma of bone.Results:A 67-year-old female patient presented to our rheumatology department with back and left radicular pain of brutal onset, 15 days prior to her visit. Pain was severe and awakened her at nights. On examination, mobilities of the spine were unchanged but on palpation she had exquisite pain of L4. Laboratory tests showed a normal sedimentation rate of 15mm the first hour, a negative c-reactive protein, normal calcemia and kidney tests. X-rays of lumbar spine showed a vertebral fracture with a destruction over 50% of the vertebral size and cortical rupture. MRI of the spine showed the absence of other lytic lesions or other fractures or spinal cord compression and showed the total destruction oft he anterior vertebral body of L4 (Figure 1). Protein electrophoresis was in normal range and 24h urinary proteinuria was negative. Other tests rules out gynecological, thyroid, and renal neoplasms. Sternal puncture showed a rich bone marrow of normal cells without further infiltration. Bone biopsy of the detected lesion showed tumour cells made of mature plasmocytes confirming the diagnosis of solitary plasmocytoma of the bone. The patient was treated with radiation therapy. The evolution after 24 months showed a stabalised lesion and the absence of progression to multiple myeloma.Figure 1.T2 weighted MRI showing the vertebral fracture of L4Conclusion:It is important to keep in mind the diagnosis of solitary plasmocytoma of bone when facing a solitary lesion or vertebral fracture despite relatively non agressive radiological signs. It is also important to note the possible evolution to multiple myeloma and keep a hawk-eyed guard.References:[1]Masmoudi K, Elleuch E, Akrout R, et al. Le plasmocytome solitaire osseux: à propos de 3 cas et revue de la littérature. Pan Afr Med J; 25. Epub ahead of print 6 December 2016. DOI: 10.11604/pamj.2016.25.219.10933.Disclosure of Interests:None declared

2011 ◽  
Vol 61 (6) ◽  
pp. 390-393
Author(s):  
Young Soo Song ◽  
Young-Ha Oh ◽  
Yong Wook Park ◽  
Ye-Soo Park

2021 ◽  
Vol 0 ◽  
pp. 0-0
Author(s):  
Janpreet S. Bhandohal ◽  
Leila Moosavi ◽  
Igor Garcia-Pacheco ◽  
Gian Yakoub ◽  
Rahul D. Polineni ◽  
...  

2017 ◽  
Vol 20 (4) ◽  
pp. 178-180
Author(s):  
Simon Binny ◽  
Stephen Tomlinson ◽  
Christopher Hammett ◽  
Arun Dahiya ◽  
Elango Pillai ◽  
...  

2017 ◽  
Vol 16 (1) ◽  
pp. 142-145
Author(s):  
Bimal K Agrawal ◽  
Anshul Sehgal ◽  
Vikas Deswal ◽  
Prem Singh ◽  
Usha Agrawal

Multiple myeloma is a neoplasm of plasma cells in the bone marrow. It is characterised by lytic lesions in the bones, marrow plasmacytosis and presence of M protein in serum and/or urine. Serum ?2 microglobulin is also raised and can be used for classification and prognostication of the disease. In the absence of M protein, the disease is known as non-secretory myeloma. It is proposed that raised ?2 microglobulin can be used for diagnosis and therapeutic guidance in the absence of M protein. A rare case of nonsecretory myeloma with neurocognitive impairment along with review of literature is being presented. The patient had multiple lytic lesions in bones with marked increase in plasma cells in bone marrow. M protein was not detectable in serum or urine but serum ?2 microglobulin was much elevated.Bangladesh Journal of Medical Science Vol.16(1) 2017 p.142-145


Cancers ◽  
2020 ◽  
Vol 12 (11) ◽  
pp. 3155
Author(s):  
Sébastien Mulé ◽  
Edouard Reizine ◽  
Paul Blanc-Durand ◽  
Laurence Baranes ◽  
Pierre Zerbib ◽  
...  

Bone disease is one of the major features of multiple myeloma (MM), and imaging has a pivotal role in both diagnosis and follow-up. Whole-body magnetic resonance imaging (MRI) is recognized as the gold standard for the detection of bone marrow involvement, owing to its high sensitivity. The use of functional MRI sequences further improved the performances of whole-body MRI in the setting of MM. Whole-body diffusion-weighted (DW) MRI is the most attractive functional technique and its systematic implementation in general clinical practice is now recommended by the International Myeloma Working Group. Whole-body dynamic contrast-enhanced (DCE) MRI might provide further information on lesions vascularity and help evaluate response to treatment. Whole Body PET/MRI is an emerging hybrid imaging technique that offers the opportunity to combine information on morphology, fat content of bone marrow, bone marrow cellularity and vascularization, and metabolic activity. Whole-body PET/MRI allows a one-stop-shop examination, including the most sensitive technique for detecting bone marrow involvement, and the most recognized technique for treatment response evaluation. This review aims at providing an overview on the value of whole-body MRI, including DW and DCE MRI, and combined whole-body 18F-FDG PET/MRI in diagnosis, staging, and response evaluation in patients with MM.


2018 ◽  
Vol 2018 ◽  
pp. 1-5
Author(s):  
A. Raissi ◽  
Z. Chahbi ◽  
M. Zyani ◽  
Y. Darouassi

Multiple myeloma is a plasma cell dyscrasis characterized by mature B cells proliferation in the bone marrow. In rare cases, the disease can present as an extramedullary location, making diagnosis and management more challenging. Here, we describe a rare case of tongue extramedullary myeloma and discuss diagnostic, prognostic, and therapeutic issues.


1989 ◽  
Vol 75 (2) ◽  
pp. 90-96 ◽  
Author(s):  
Massimo Federico ◽  
Richard L. Magin ◽  
Harold M. Swartz ◽  
Robert M. Wright ◽  
Vittorio Silingardi

Current methods for the study of bone marrow to evaluate possible primary or metastatic cancers are reviewed. Bone marrow biopsy, radionuclide scan, computed tomography and magnetic resonance imaging (MRI) are analyzed with regard to their clinical usefulness at the time of diagnosis and during the course of the disease. Bone marrow biopsy is still the examination of choice not only in hematologic malignancies but also for tumors that metastasize into the marrow. Radionuclide scans are indicated for screening for skeletal metastases, except for those from thyroid carcinoma and multiple myeloma. Computed tomography is useful for cortical bone evaluation. MRI shows a high sensitivity in finding occult sites of disease in the marrow but its use has been restricted by high cost and limited availability. However, the future of MRI in bone marrow evaluation seems assured. MRI is already the method of choice for diagnosis of multiple myeloma, when radiography is negative, and for quantitative evaluation of lymphoma when a crucial therapeutic decision (i.e. bone marrow transplantation) must be made. Finally, methods are being developed that will enhance the sensitivity and specificity of MRI studies of bone marrow.


2011 ◽  
Vol 50 (14) ◽  
pp. 1483-1487 ◽  
Author(s):  
Hisanori Machida ◽  
Tsutomu Shinohara ◽  
Hiroyuki Hino ◽  
Mitsuteru Yoshida ◽  
Nobuo Hatakeyama ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document